RE: FDA news11 Jun 2021 10:46
I'm going to sound a note of caution around the FDA action and what it might mean for ODX (and associates).
Firstly one has to remember that, due the litigious nature of commerce and healthcare in the USA, the FDA is often far quicker to require withdrawal of devices from market than other competent authorities.
Secondly, we also have to remember that two of the Innova tests (there's more than one) have been independently assessed by PHE Porton Down. If we call into question their assessment of the Innova tests, that also would call into question their assessment of all LFTs - including ours/Mologics.
Thirdly, the likes of Deeks and the other Covidiots will use this as a stick to beat and undermine *all* LFTs, as they have an irrational dislike of them as a testing tool per se. It's already beginning to happen on social media.
Fourthly, this has the potential to impact on the government decision-making process. One might hope that they'd be sensible and scale up the roll out of sovereign tests - but then you have to take into account the final decision will rest with Johnson and Hand****, who have repeatedly demonstrated that they are incapable of taking a decision in the public interest.
I sincerely hope that this works in the favour of ODX in the long term... but I think the next few weeks may be something of a bumpy ride. There are a lot of idiots, charlatans and people with axes to grind out there who will use this FDA recall to push their agendas.